개인 맞춤형 장내 미생물군 보충제 시장 예측(-2034년) : 제품 유형, 성분, 섭취 형태, 용도, 유통 채널, 최종사용자 및 지역별 분석

According to Stratistics MRC, the Global Personalized Gut Microbiome Supplements Market is accounted for $4.2 billion in 2026 and is expected to reach $10.1 billion by 2034 growing at a CAGR of 11.5% during the forecast period. Personalized gut microbiome supplements refer to dietary products formulated with probiotics, prebiotics, synbiotics, or postbiotics that are tailored to an individual's unique gut microbial composition based on testing and analysis. These supplements utilize advanced microbiome sequencing and AI-driven algorithms to identify specific strains and dosages that can restore balance, improve digestion, and enhance overall health. They are designed to address the growing consumer demand for precision nutrition and personalized wellness solutions.

Market Dynamics:

Driver:

Rising Consumer Interest in Gut Health and Wellness

The increasing scientific evidence linking gut microbiome diversity to overall health, including immunity, mental wellness, and metabolic function, is driving consumer interest in personalized gut health solutions. The growing availability of direct-to-consumer microbiome testing kits is empowering individuals to understand their unique microbial profiles and seek targeted interventions. This shift towards proactive, data-driven health management is accelerating the adoption of personalized supplements, thereby fueling market growth.

Restraint:

High Costs and Regulatory Hurdles

The significant costs associated with microbiome sequencing, AI-driven analysis, and customized formulation present a barrier to mass-market adoption, limiting accessibility to premium consumer segments. The complex and evolving regulatory landscape for personalized supplements, particularly concerning health claims and data privacy, creates compliance challenges for manufacturers. The lack of standardized testing protocols and the need for clinical validation further hinder market expansion.

Opportunity:

Integration with Digital Health Platforms

The integration of personalized gut microbiome supplements with digital health platforms, mobile apps, and wearable devices presents a significant opportunity to offer comprehensive, real-time health management solutions. By combining microbiome data with lifestyle and dietary information, these platforms can provide dynamic recommendations and continuous monitoring. The growing ecosystem of digital health tools and the increasing consumer comfort with health data sharing are creating new avenues for product innovation and customer engagement.

Threat:

Data Privacy and Security Risks

The collection and storage of highly sensitive genetic and microbiome data pose significant privacy and security risks, making these platforms a prime target for cyberattacks and data breaches. A major security incident could severely erode consumer trust and lead to substantial regulatory penalties. The potential for misinterpretation of microbiome data by consumers without professional guidance also poses a threat to the credibility of the entire personalized nutrition industry.

Covid-19 Impact:

The pandemic initially disrupted supply chains for probiotic ingredients and microbiome testing kits, causing delivery delays. During the mid-pandemic period, heightened consumer focus on immunity and overall health drove significant interest in gut health and personalized supplements. Post-pandemic, the market has sustained strong growth with increased adoption of direct-to-consumer testing and customized formulations.

The probiotic supplements segment is expected to be the largest during the forecast period

The probiotic supplements segment is expected to account for the largest market share during the forecast period, due to their extensive clinical research, broad consumer familiarity, and proven efficacy in supporting digestive and immune health, making them the foundational product in the category. This segment benefits from a well-established supply chain and a wide range of available strains that can be tailored for personalized formulations. The continuous discovery of new probiotic strains with specific health benefits further reinforces its dominance in the market.

The gummies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the gummies segment is predicted to witness the highest growth rate, driven by their superior convenience, pleasant taste, and high consumer appeal, particularly among adults seeking an enjoyable alternative to traditional capsules and powders. This format masks the often-unpleasant taste of probiotic and prebiotic ingredients while offering precise dosing and portability. The rapid expansion of functional confectionery and increased marketing to health-conscious consumers are in turn accelerating the adoption of gummies as a preferred delivery format.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high consumer awareness of gut health, strong spending on dietary supplements, and a well-established direct-to-consumer health testing infrastructure in the United States. The presence of major players like Nestle Health Science and Garden of Life further reinforces the region's market leadership in personalized microbiome nutrition.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to the large population, increasing disposable incomes, and growing awareness of gut health and personalized nutrition in countries like China, India, and Japan. The rapid expansion of e-commerce and digital health platforms is making personalized microbiome solutions more accessible to consumers across the region.

Key players in the market

Some of the key players in Personalized Gut Microbiome Supplements Market include Nestle Health Science, Danone S.A., Chr. Hansen Holding A/S, Novonesis, Kerry Group plc, Culturelle (i-Health Inc.), Garden of Life, Seed Health, Pendulum Therapeutics, ADM, BioGaia AB, Probi AB, Lallemand Inc., Yakult Honsha Co., Ltd., Clasado Biosciences and Morinaga Milk Industry Co., Ltd.

Key Developments:

In July 2026, Nestle Health Science launched a new AI-powered platform that integrates microbiome testing with personalized supplement recommendations for digestive and immune health.

In June 2026, Seed Health announced a partnership with a leading genetic testing company to integrate microbiome analysis with DNA insights, enabling highly personalized wellness recommendations, precision nutrition strategies, and customized supplement formulations for improved individual health outcomes.

In May 2026, Novonesis introduced a novel probiotic strain designed for personalized formulations targeting metabolic health and weight management, supporting tailored nutrition solutions, enhanced gut microbiome balance, improved metabolic function, and individualized consumer wellness programs.

Product Types Covered:

• Probiotic Supplements
• Prebiotic Supplements
• Synbiotic Supplements
• Postbiotic Supplements
• Microbiome Testing & Supplement Kits
• Customized Microbiome Formulations

Ingredients Covered:

• Lactobacillus
• Bifidobacterium
• Saccharomyces boulardii
• Inulin
• Fructooligosaccharides (FOS)

Delivery Formats Covered:

• Capsules
• Tablets
• Powders
• Gummies
• Liquid Formulations
• Sachets

Applications Covered:

• Digestive Health
• Immune Health
• Weight Management
• Mental Wellness
• Metabolic Health
• Women's Health
• Healthy Aging

Distribution Channels Covered:

• Pharmacies & Drug Stores
• Supermarkets & Hypermarkets
• Health & Wellness Stores
• E-Commerce
• Direct-to-Consumer
• Practitioner Clinics

End Users Covered:

• Adults
• Children
• Seniors
• Athletes
• Pregnant Women
• Other End Users

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Personalized Gut Microbiome Supplements Market, By Product Type

• 5.1 Probiotic Supplements
• 5.2 Prebiotic Supplements
• 5.3 Synbiotic Supplements
• 5.4 Postbiotic Supplements
• 5.5 Microbiome Testing & Supplement Kits
• 5.6 Customized Microbiome Formulations

6 Global Personalized Gut Microbiome Supplements Market, By Ingredient

• 6.1 Lactobacillus
• 6.2 Bifidobacterium
• 6.3 Saccharomyces boulardii
• 6.4 Inulin
• 6.5 Fructooligosaccharides (FOS)

7 Global Personalized Gut Microbiome Supplements Market, By Delivery Format

• 7.1 Capsules
• 7.2 Tablets
• 7.3 Powders
• 7.4 Gummies
• 7.5 Liquid Formulations
• 7.6 Sachets

8 Global Personalized Gut Microbiome Supplements Market, By Application

• 8.1 Digestive Health
• 8.2 Immune Health
• 8.3 Weight Management
• 8.4 Mental Wellness
• 8.5 Metabolic Health
• 8.6 Women's Health
• 8.7 Healthy Aging

9 Global Personalized Gut Microbiome Supplements Market, By Distribution Channel

• 9.1 Pharmacies & Drug Stores
• 9.2 Supermarkets & Hypermarkets
• 9.3 Health & Wellness Stores
• 9.4 E-Commerce
• 9.5 Direct-to-Consumer
• 9.6 Practitioner Clinics

10 Global Personalized Gut Microbiome Supplements Market, By End User

• 10.1 Adults
• 10.2 Children
• 10.3 Seniors
• 10.4 Athletes
• 10.5 Pregnant Women
• 10.6 Other End Users

11 Global Personalized Gut Microbiome Supplements Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 Nestle Health Science
• 14.2 Danone S.A.
• 14.3 Chr. Hansen Holding A/S
• 14.4 Novonesis
• 14.5 Kerry Group plc
• 14.6 Culturelle (i-Health Inc.)
• 14.7 Garden of Life
• 14.8 Seed Health
• 14.9 Pendulum Therapeutics
• 14.10 ADM
• 14.11 BioGaia AB
• 14.12 Probi AB
• 14.13 Lallemand Inc.
• 14.14 Yakult Honsha Co., Ltd.
• 14.15 Clasado Biosciences
• 14.16 Morinaga Milk Industry Co., Ltd.